SCHEMBL14033017

SCHEMBL14033017

CCCc1cc(C)cc(F)c1C

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
HMGCR P04035 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HTT P42858 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
XBP1 P17861 1/20 0.32
HIF1A Q16665 1/20 0.32
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
ALDH1A2 O94788 1/20 0.30
ALDH2 P05091 1/20 0.30
TSHR P16473 1/20 0.30
ALDH1B1 P30837 1/20 0.30
ALDH1A3 P47895 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19847518 0.85 FFAR4 (0.39) TAAR1MAPTLMNAXBP1HIF1A
SCHEMBL29314259 0.83 NOS1 (0.39) NOS3NOS1NOS2HMGCRALDH1A1
SCHEMBL12700587 0.82 HDAC1 (0.38) NOS3NOS2ALDH1A1HTTTAAR1
SCHEMBL14032753 0.79 HMGCR (0.40) NOS3NOS1NOS2HMGCRALDH1A1
SCHEMBL23742694 0.78 TAAR1 (0.50) NOS3NOS1NOS2ALDH1A1HTT
SCHEMBL21386534 0.77 HDAC1 (0.33) TAAR1HDAC1HDAC6
SCHEMBL14629779 0.76 HDAC1 (0.32) HDAC1HDAC6
SCHEMBL26938483 0.75 TAAR1 (0.39) NOS3NOS1NOS2ALDH1A1HTT
SCHEMBL14528957 0.74 TAAR1 (0.45) HMGCRTAAR1TSHR
SCHEMBL9921236 0.74 TAAR1 (0.41) HMGCRTAAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3739020-B1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2023-08-23 EP disclosed
EP-3739020-A1 LIQUID-CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2020-11-18 EP disclosed
EP-3543314-B1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2020-09-09 EP disclosed
EP-3543313-A1 LIQUID-CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2019-09-25 EP disclosed
US-7435455-B2 Dihydrocoumarin derivative, liquid crystal composition containing the same, and liquid crystal display device CHISSO CORPORATION (JP) 2008-10-14 US disclosed